西格医学 (873450.OC)

+ 收藏

利润表(西格医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 35,410,618.3168,919,059.1726,905,496.3952,980,961.9617,603,882.51
 营业收入(元) 35,410,618.3168,919,059.1726,905,496.3952,980,961.9617,603,882.51
二、营业总成本(元) 21,639,214.2346,560,831.9717,516,282.1335,769,710.5613,028,010.49
 营业成本(元) 14,505,819.1931,160,310.9210,900,836.8721,136,341.327,552,077.44
 研发费用(元) 2,546,916.195,852,333.302,665,457.165,812,977.541,927,204.40
 营业税金及附加(元) 206,358.37480,548.13195,359.27347,275.34117,412.42
 销售费用(元) 1,242,755.693,156,066.54902,279.682,635,639.35610,043.75
 管理费用(元) 3,136,344.365,624,574.972,650,386.855,375,637.772,610,899.90
 财务费用(元) 1,020.43286,998.11201,962.30461,839.24210,372.58
  其中:利息费用(元) 22,840.95305,429.13205,014.24470,204.11213,329.88
  其中:利息收入(元) 24,260.2422,285.185,825.8413,192.805,856.23
三、其他经营收益
 加:公允价值变动收益(元) -2,000,000.00-3,117,945.21743,863.011,094,377.62511,405.85
 加:投资收益(元) 103,442.41553,815.48167,109.31704,926.79422,584.61
  其中:对联营企业和合营企业的投资收益(元) -1,597.00-943.65-462.19--45,762.87
 信用减值损失(元) -1,393,035.15-1,310,177.12-621,002.97-385,837.84136,197.16
 其他收益(元) 67,620.991,699,399.97378,359.041,063,236.05179,573.94
四、营业利润(元) 10,549,432.3320,183,320.3210,057,542.6519,687,954.025,825,633.58
 加:营业外收入(元) 0.7396.3614.9079.430.30
 减:营业外支出(元) 200.7149.90-25,569.11-
五、利润总额(元) 10,549,232.3520,183,366.7810,057,557.5519,662,464.345,825,633.88
 减:所得税费用(元) 1,332,496.452,238,803.28994,384.782,235,302.26932,645.07
六、净利润(元) 9,216,735.9017,944,563.509,063,172.7717,427,162.084,892,988.81
(一)按经营持续性分类
  持续经营净利润(元) 9,216,735.90-9,063,172.77--
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 9,156,066.2618,005,339.609,204,088.9017,493,159.865,082,186.55
  少数股东损益(元) 60,669.64-60,776.10-140,916.13-65,997.78-189,197.74
 扣除非经常性损益后的净利润(元) 10,769,931.3918,896,140.738,131,544.3015,126,811.634,097,296.06
七、每股收益
 一、基本每股收益(元) 0.350.680.520.990.95
 二、稀释每股收益(元) 0.350.680.520.990.95
八、其他综合收益(元) ----69,468.61-
 归属于母公司股东的其他综合收益(元) ----69,468.61-
九、综合收益总额(元) 9,216,735.9017,944,563.509,063,172.7717,357,693.474,892,988.81
 归属于母公司所有者的综合收益总额(元) 9,156,066.2618,005,339.609,204,088.9017,423,691.255,082,186.55
 归属于少数股东的综合收益总额(元) 60,669.64-60,776.10-140,916.13-65,997.78-189,197.74
公告日期 2024-08-162024-04-252023-08-092023-03-172022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院